Capital World Investors
RVMD icon

Capital World Investors’s Revolution Medicines RVMD Stock Holding History

Capital World Investors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,228,000
Closed -$31.3M – 586
2022
Q1 		$31.3M Hold
1,228,000
– – 0.01% 463
2021
Q4 		$30.9M Hold
1,228,000
– – ﹤0.01% 499
2021
Q3 		$33.8M Hold
1,228,000
– – 0.01% 495
2021
Q2 		$39M Hold
1,228,000
– – 0.01% 474
2021
Q1 		$56.3M Hold
1,228,000
– – 0.01% 422
2020
Q4 		$48.6M Hold
1,228,000
– – 0.01% 409
2020
Q3 		$42.7M Buy
1,228,000
+307,547
+33% +$8.52M 0.01% 405
2020
Q2 		$29.1M Buy
920,453
+50,919
+6% +$1.6M 0.01% 403
2020
Q1 		$19.1M Buy
+869,534
New +$24.1M 0.01% 403

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Capital World Investors's RVMD Position: Q2 2022 in Review

Capital World Investors sold out of Revolution Medicines (RVMD) in Q2 2022, closing a stake of 1,228,000 shares — an estimated $31.3M sold.

Capital World Investors first reported a position in RVMD in Q1 2020 and held it in 9 quarters. The position peaked at $56.3M in Q1 2021. 135 funds tracked by Wall St. Rank hold RVMD as of Q2 2022.

  • Capital World Investors reported no remaining Revolution Medicines position as of Q2 2022 after selling out during the quarter.
  • Capital World Investors sold 1,228,000 Revolution Medicines shares in Q2 2022, an estimated $31.3M.
  • Capital World Investors first reported a position in Revolution Medicines in Q1 2020 and held it in 9 quarters.
  • Capital World Investors's Revolution Medicines position peaked at $56.3M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2022.

Based on Capital World Investors's 13F filing for Q2 2022, filed 15 Aug 2022.